Company intelligence / Profile preview

Qlucore

Lund, Skåne, Sweden

Ownership: Private
Employees: ~25
Development stage: Other

Overview

Qlucore has commercialized visualization-based bioinformatics solutions for research and clinical workflows, with the launch of its CE-marked diagnostic test for pediatric leukemia (BCP-ALL), and offers market-ready platforms for omics data analysis, disease subtyping, and precision diagnostics[6].

Therapeutic areas: OncologyOther
Modalities: SoftwareAI-powered machine learning classifierCompanion diagnosticPrecision diagnostic
Industry: Molecular Diagnostics

Partnerships

Rigshospitalet (Denmark)Multiple research institutions (academic collaborations)

Beyond the preview

Go deeper on Qlucore.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Qlucore.

Explore the full profile